Marle is an independent implant contract manufacturing company in Europe.
On May 25, Willkie client IK Investment Partners announced that IK VII Fund has agreed to acquire a majority stake in Marle International SAS, an independent implant contract manufacturing company in Europe, from The Carlyle Group. Carlyle’s Europe Technology fund, majority shareholder since 2009, will reinvest alongside management and the Marle family.
Marle has a 30-year track record serving the orthopedic implant industry and specializes in the precision forging, machining and finishing of hip knee, shoulder, spine and extremities implants as well as instruments.
IK Investment Partners is a pan-European private equity firm focused on investments in the Nordics, DACH region, France and Benelux.
The Willkie deal team was led by partner Eduardo Fernandez and included partner Paul Lombard and national partner Grégory de Saxcé.